Literature DB >> 32187498

Potential Contribution of Pulmonary Thromboembolic Disease in Pulmonary Hypertension in Sickle Cell Disease.

Mehdi Nouraie1, Xu Zhang2, Andrew Srisuwananukorn2, Roberto F Machado3, Victor R Gordeuk2, Mark T Gladwin1, Santosh Saraf2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32187498      PMCID: PMC7328185          DOI: 10.1513/AnnalsATS.201911-840RL

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


× No keyword cloud information.
  10 in total

Review 1.  Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018.

Authors:  Heinrike Wilkens; Stavros Konstantinides; Irene M Lang; Alexander C Bunck; Mario Gerges; Felix Gerhardt; Aleksandar Grgic; Christian Grohé; Stefan Guth; Matthias Held; Jan B Hinrichs; Marius M Hoeper; Walter Klepetko; Thorsten Kramm; Ulrich Krüger; Mareike Lankeit; Bernhard C Meyer; Karen M Olsson; Hans-Joachim Schäfers; Matthias Schmidt; Hans-J Seyfarth; Silvia Ulrich; Christoph B Wiedenroth; Eckhard Mayer
Journal:  Int J Cardiol       Date:  2018-08-28       Impact factor: 4.164

Review 2.  Updated clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Michael A Gatzoulis; Ian Adatia; David Celermajer; Chris Denton; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; R Krishna Kumar; Michael Landzberg; Roberto F Machado; Horst Olschewski; Ivan M Robbins; Rogiero Souza
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

3.  Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.

Authors:  Anastasia Anthi; Roberto F Machado; Maria L Jison; Angelo M Taveira-Dasilva; Lewis J Rubin; Lori Hunter; Christian J Hunter; Wynona Coles; James Nichols; Nilo A Avila; Vandana Sachdev; Clara C Chen; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2007-03-22       Impact factor: 21.405

Review 4.  Cardiovascular complications in patients with sickle cell disease.

Authors:  Mark T Gladwin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 5.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

6.  Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.

Authors:  Hossein-Ardeschir Ghofrani; Andrea M D'Armini; Friedrich Grimminger; Marius M Hoeper; Pavel Jansa; Nick H Kim; Eckhard Mayer; Gerald Simonneau; Martin R Wilkins; Arno Fritsch; Dieter Neuser; Gerrit Weimann; Chen Wang
Journal:  N Engl J Med       Date:  2013-07-25       Impact factor: 91.245

7.  Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication.

Authors:  Rakhi P Naik; Michael B Streiff; Carlton Haywood; Julie A Nelson; Sophie Lanzkron
Journal:  Am J Med       Date:  2013-05       Impact factor: 4.965

8.  Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.

Authors:  R P Naik; M B Streiff; C Haywood; J B Segal; S Lanzkron
Journal:  J Thromb Haemost       Date:  2014-10-18       Impact factor: 5.824

9.  Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.

Authors:  Mark T Gladwin; Robyn J Barst; J Simon R Gibbs; Mariana Hildesheim; Vandana Sachdev; Mehdi Nouraie; Kathryn L Hassell; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Enrico Novelli; Reda E Girgis; Claudia R Morris; Erika Berman Rosenzweig; David B Badesch; Sophie Lanzkron; Oswaldo L Castro; James G Taylor; Jonathan C Goldsmith; Gregory J Kato; Victor R Gordeuk; Roberto F Machado
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

10.  Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis.

Authors:  Mazou N Temgoua; Ronni Tankeu; Joel Noutakdie Tochie; Jean Jacques Noubiap; Ambroise Wonkam; Jean Joël Bigna
Journal:  Thromb J       Date:  2018-10-04
  10 in total
  1 in total

1.  Murine models of sickle cell disease and beta-thalassemia demonstrate pulmonary hypertension with distinctive features.

Authors:  Paul W Buehler; Delaney Swindle; David I Pak; Mehdi A Fini; Kathryn Hassell; Rachelle Nuss; Rebecca B Wilkerson; Angelo D'Alessandro; David C Irwin
Journal:  Pulm Circ       Date:  2021-11-07       Impact factor: 2.886

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.